“Drug company propaganda techniques are extremely sophisticated, leveraging advanced techniques to change the medical landscape. It’s big business for them — US spending on prescription drugs jumped from $40 billion in 1990 to $234 billion in 2008 — but bad business for you” (3 Drug Company Propaganda Techniques). These ads don’t care about the people’s heath they just want money because it is nothing but a business to them. “The ads have a strong propaganda angle — happy, healthy people who’ve found that the one thing they’ve needed in life actually came in the form of a pill. This pill. The pill you need to “ask your doctor about” at your next appointment” (3 Drug Company Propaganda Techniques). Prescription drug ads find a way to attract people, especially the people that suffer from the diseases that the “pill” claims to cure. It is only natural for people to want to look and feel their best and these ads are taking advantage of
Educating women about breast cancer has become increasing important. Recently, an alarming survey, conducted by the American Cancer Society, showed that many women have incorrect perceptions about their risk of getting breast cancer. Nearly half of the women believed their chances of developing cancer were as much as fifty percent, when in reality it is only eleven percent. Also, many women thought that their risk of getting breast cancer was highest in their thirties and fourths, when in ...
"Breast Cancer Prevention: How to reduce your risk." Mayo Clinic. Mayo Clinic, n.d. Web. 9 Feb. 2014. .
Over the last several years, pharmaceutical companies have launched a campaign style called Direct to Consumer Drug Advertising or known as DTCA. This campaign has led to a large increase of clinical examinations has led to a large increase in clinical examination and this makes the pharmaceutical companies happy and helps padding their pockets. Using this type of advertising, these drug companies allow details of a particular drug to spread to a potential patient and then most likely pushed by the doctor upon visit. These types of advertising campaigns are focused on trying to “enrich” the consumer (Relman p28). Even though this type of advertising campaign allows most drugs to be cheaper overall, consumers should be concerned about the ethical and psychological effect it might have because of the type of massive advertising campaign it has become. This particular study will go on to explain the unethical impact a campaign like this has on side effects and addictions (Findlay p39).
Women who use any or all of these measures reduce their risk of breast cancer. Even so, these women are still in jeopardy of contracting breast cancer. The fact is, the specific cause of breast cancer is unknown. These treatment options do not guarantee that at risk women will not be burdened with this deadly disease. What is needed to eliminate complete...
The relationship between doctors and drug companies has been well established and well documented. Major news media resources like The Atlantic, as well as professional peer-reviewed journals like the New England Journal of Medicine cover stories addressing the potential ethical puzzles between physicians and pharmaceutical companies. Shaywitz (2013) has described the problem as “a bunch of wicked pushers who pay off vulnerable doctors to prescribe their latest expensive, mediocre product,” while still defending the special relationship that has developed between doctors and pharmaceutical companies (p. 1). Shaywitz’s (2013) argument is based on opinion on estimate only. Most established professional journals imply that collusion between doctors and drug companies leads to a range of problems that potentially harm patients. Writing for the British Medical Journal, Moynihan (2003) locates actual empirical evidence showing that doctors’ prescribing habits changes measurably after the skillful marketing techniques used by pharmaceutical industry representatives: techniques ranging from free ...
Breast Cancer is defined as “a group of solid tumor malignancies arising in the tissues of the breast” (Sarah Crawford, Richard Alder, 2013) in human and other mammals. It can happen to both men and women. For women, breast cancer is one of the leading causes of cancer death. According to National Cancer Institute, in the United States, the 2014 estimated new cases and deaths of female from breast cancer are 232,670 and 40,000, respectively. For male, it’s 430 deaths out of 2,360 new cases. From these numbers, we can see that women in the U.S. are greatly affected by breast cancer, thus, it’s not difficult to imagine the impact on a worldwide level. Although these numbers look frightening, people can actually survive from breast cancer if it is detected early and treated properly, so it is extremely important for all of us, especially women, to have a better understanding of breast cancer.
Breast cancer is known as the most common solid tumor among the female population in most parts of the world [WHO 2012], second only to skin cancer in the United States [Ma 2013]. In 2014, an estimated 235,030 new cases of breast cancer (BCA) will occur in the United States [Siegel 2014] with an average of 1 in 8 women developing BCA at some point in their lifetime. While this incidence has remained relatively stable since 2004, mortality rates have progressively declined by over 30% in the last two decades [ACS 2013]. This improved survival is due to a multitude of factors including early detection, public awareness, multidisciplinary approach to diagnosis and treatment, ongoing clinical trials, and advances in treatment [Bleyer 2012, Smith 2013, Mangat 2011].
The fear of having breast cancer is prevalent for many women. There are a few breast cancer risk factors that cannot be changed for women. Gender plays a role in risk. Women are far more likely to have breast cancer than men (U.S. National Library of Medicine, 2014). The inheritance of a mutated gene such as the BRCA1 or BRCA2 and women who received their period before the age of 12 have a greater risk. Inheritance of breast cancer is not the cause for most breast cancer patients (American Cancer Society, 2011). Some changeable lifestyle factors can attribute to breast cancer....
Pharmaceutical companies have a wide variety of scientific evidence based on their previous and most recent clinical trials on every type of drug they introduce in the advertising world. However, one of the few problems they are facing is that there is too much information being presented to the consumer during broadcast advertisements. In turn due to the overwhelming amount of information, consumers are missing key medical facts that are needed to make an informed decision regarding their health. While all ads appear to list both the positives and negatives of the medication, some advertisements may be more misleading than others.